These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10559005)

  • 1. Focal expression of angiotensin II type 1 receptor and smooth muscle cell proliferation in the neointima of experimental vein grafts: relation to eddy blood flow.
    Liu SQ
    Arterioscler Thromb Vasc Biol; 1999 Nov; 19(11):2630-9. PubMed ID: 10559005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of focal intimal hyperplasia in rat vein grafts by using a tissue engineering approach.
    Liu SQ
    Atherosclerosis; 1998 Oct; 140(2):365-77. PubMed ID: 9862280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in the organization of the smooth muscle cells in rat vein grafts.
    Liu SQ; Fung YC
    Ann Biomed Eng; 1998; 26(1):86-95. PubMed ID: 10355553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-365 promotes the contractile phenotype of venous smooth muscle cells and inhibits neointimal formation in rat vein grafts.
    Cao BJ; Zhu L; Wang XW; Zou RJ; Lu ZQ
    IUBMB Life; 2019 Jul; 71(7):908-916. PubMed ID: 30746857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-221 sponge therapy attenuates neointimal hyperplasia and improves blood flows in vein grafts.
    Wang XW; He XJ; Lee KC; Huang C; Hu JB; Zhou R; Xiang XY; Feng B; Lu ZQ
    Int J Cardiol; 2016 Apr; 208():79-86. PubMed ID: 26828387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of smooth muscle cell phenotypic modulation with extracellular matrix alterations during neointima formation in rabbit vein grafts.
    Zhang WD; Bai HZ; Sawa Y; Yamakawa T; Kadoba K; Taniguchi K; Masuda J; Ogata J; Shirakura R; Matsuda H
    J Vasc Surg; 1999 Jul; 30(1):169-83. PubMed ID: 10394167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterisation of angiotensin II receptor mediated responses and inhibition of intimal hyperplasia in experimental vein grafts by the specific angiotensin II receptor inhibitor, L158,809.
    Davies MG; Fulton GJ; Barber L; Dalen H; Svendsen E; Hagen PO
    Eur J Vasc Endovasc Surg; 1996 Aug; 12(2):151-61. PubMed ID: 8760976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of mechanical stretch-induced endothelial and smooth muscle cell injury in experimental vein grafts.
    Liu SQ; Moore MM; Yap C
    J Biomech Eng; 2000 Feb; 122(1):31-8. PubMed ID: 10790827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of external stenting and systemic hypertension on intimal hyperplasia in rat vein grafts.
    Meguro T; Nakashima H; Kawada S; Tokunaga K; Ohmoto T
    Neurosurgery; 2000 Apr; 46(4):963-9; discussion 969-70. PubMed ID: 10764272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-33 protects against neointimal hyperplasia induced by arterial mechanical stretch in the grafted vein.
    Huang K; Bao H; Yan ZQ; Wang L; Zhang P; Yao QP; Shi Q; Chen XH; Wang KX; Shen BR; Qi YX; Jiang ZL
    Cardiovasc Res; 2017 Apr; 113(5):488-497. PubMed ID: 28137944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Girdin in intimal hyperplasia in vein grafts and efficacy of atelocollagen-mediated application of small interfering RNA for vein graft failure.
    Miyachi H; Mii S; Enomoto A; Murakumo Y; Kato T; Asai N; Komori K; Takahashi M
    J Vasc Surg; 2014 Aug; 60(2):479-489.e5. PubMed ID: 23948670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of platelet-derived growth factor receptor-alpha and -beta blockade on flow-induced neointimal formation in endothelialized baboon vascular grafts.
    Davies MG; Owens EL; Mason DP; Lea H; Tran PK; Vergel S; Hawkins SA; Hart CE; Clowes AW
    Circ Res; 2000 Apr; 86(7):779-86. PubMed ID: 10764412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term stabilization of vein graft wall architecture and prolonged resistance to experimental atherosclerosis after E2F decoy oligonucleotide gene therapy.
    Ehsan A; Mann MJ; Dell'Acqua G; Dzau VJ
    J Thorac Cardiovasc Surg; 2001 Apr; 121(4):714-22. PubMed ID: 11279413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled periadventitial administration of verapamil inhibits neointimal smooth muscle cell proliferation and ameliorates vasomotor abnormalities in experimental vein bypass grafts.
    Brauner R; Laks H; Drinkwater DC; Chaudhuri G; Shvarts O; Drake T; Bhuta S; Mishaly D; Fishbein I; Golomb G
    J Thorac Cardiovasc Surg; 1997 Jul; 114(1):53-63. PubMed ID: 9240294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neointimal-specific induction of apoptosis by losartan results in regression of vascular lesion in rat aorta.
    Lemay J; Hale TM; deBlois D
    Eur J Pharmacol; 2009 Sep; 618(1-3):45-51. PubMed ID: 19619526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-26a targets MAPK6 to inhibit smooth muscle cell proliferation and vein graft neointimal hyperplasia.
    Tan J; Yang L; Liu C; Yan Z
    Sci Rep; 2017 Apr; 7():46602. PubMed ID: 28429763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [SMC proliferation and its distribution in autologous vein grafts].
    Zhang B; Qian H; Kuang Y
    Zhonghua Wai Ke Za Zhi; 1996 Jul; 34(7):405-8. PubMed ID: 9590791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential response of arteries and vein grafts to blood flow reduction.
    Galt SW; Zwolak RM; Wagner RJ; Gilbertson JJ
    J Vasc Surg; 1993 Mar; 17(3):563-70. PubMed ID: 8445753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle.
    Wang CH; Li SH; Weisel RD; Fedak PW; Dumont AS; Szmitko P; Li RK; Mickle DA; Verma S
    Circulation; 2003 Apr; 107(13):1783-90. PubMed ID: 12665485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GR144053, a fibrinogen receptor antagonist, enhances the suppression of neointima formation by losartan, an angiotensin II receptor antagonist, in the injured carotid artery of hamster.
    Matsuno H; Kozawa O; Niwa M; Kaida T; Hayashi H; Uematsu T
    Br J Pharmacol; 1997 Nov; 122(6):1099-104. PubMed ID: 9480031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.